Home NDC 46287-020 CaroSpir
Product NDC 46287-020
11-digit product format 462870020
Labeler code 46287
Product ID 46287-020_341fea14-cdc7-4c75-b1ca-706e90dc0128
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CaroSpir
Dosage form SUSPENSION
Route ORAL
Labeler CMP Pharma, Inc.
Application NDA209478
Marketing category NDA
Marketing start 2017-08-04
Substance SPIRONOLACTONE
Active strength 25 mg/5mL
Pharmacologic classes Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209478-001 CAROSPIR SPIRONOLACTONE 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N209478-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209478-001 10493083 2036-10-28 Drug product 2020-01-02 N209478-001 10624906 2036-10-28 Drug product 2020-04-27 N209478-001 10660907 2036-10-28 Drug product 2020-06-15 N209478-001 10888570 2036-10-28 Drug product 2021-01-15 N209478-001 11389461 2036-10-28 Drug product 2022-07-22 N209478-001 11395828 2036-10-28 U-2109 2022-08-02 N209478-001 11395828 2036-10-28 U-3401 2022-08-02 N209478-001 11395828 2036-10-28 U-3402 2022-08-02 N209478-001 11491166 2036-10-28 Drug product 2022-11-18 N209478-001 9757394 2036-10-28 U-2109 Drug product 2017-09-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL AB RLD, RS 2017-08-04 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209478-001 CAROSPIR 25MG/5ML SUSPENSION / ORAL RLD, RS 2017-08-04 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 9 · 329 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209478-001 10493083 2036-10-28 Drug product 2020-01-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 10624906 2036-10-28 Drug product 2020-04-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 10660907 2036-10-28 Drug product 2020-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 10888570 2036-10-28 Drug product 2021-01-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 11389461 2036-10-28 Drug product 2022-07-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 11395828 2036-10-28 U-2109 2022-08-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 11395828 2036-10-28 U-3401 2022-08-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 11395828 2036-10-28 U-3402 2022-08-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 11491166 2036-10-28 Drug product 2022-11-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209478-001 9757394 2036-10-28 U-2109 Drug product 2017-09-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209478-001 10493083 2036-10-28 Drug product 2020-01-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 10624906 2036-10-28 Drug product 2020-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 10660907 2036-10-28 Drug product 2020-06-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 10888570 2036-10-28 Drug product 2021-01-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 11389461 2036-10-28 Drug product 2022-07-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 11395828 2036-10-28 U-2109 2022-08-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 11395828 2036-10-28 U-3401 2022-08-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 11395828 2036-10-28 U-3402 2022-08-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 11491166 2036-10-28 Drug product 2022-11-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209478-001 9757394 2036-10-28 U-2109 Drug product 2017-09-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 10493083 2036-10-28 Drug product 2020-01-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 10624906 2036-10-28 Drug product 2020-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 10660907 2036-10-28 Drug product 2020-06-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 10888570 2036-10-28 Drug product 2021-01-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 11389461 2036-10-28 Drug product 2022-07-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 11395828 2036-10-28 U-2109 2022-08-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 11395828 2036-10-28 U-3401 2022-08-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 11395828 2036-10-28 U-3402 2022-08-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 11491166 2036-10-28 Drug product 2022-11-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209478-001 9757394 2036-10-28 U-2109 Drug product 2017-09-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209478-001 10493083 2036-10-28 Drug product 2020-01-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 10624906 2036-10-28 Drug product 2020-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 10660907 2036-10-28 Drug product 2020-06-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 10888570 2036-10-28 Drug product 2021-01-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 11389461 2036-10-28 Drug product 2022-07-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 11395828 2036-10-28 U-2109 2022-08-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 11395828 2036-10-28 U-3401 2022-08-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 11395828 2036-10-28 U-3402 2022-08-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 11491166 2036-10-28 Drug product 2022-11-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209478-001 9757394 2036-10-28 U-2109 Drug product 2017-09-21 6a471c1ec25d…
Additional Listing Data#
Finished product Yes
Brand name base CaroSpir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SPIRONOLACTONE 25 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 27O7W4T232 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 104232 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 46287-020-01 CaroSpir 473 mL in 1 BOTTLE Suspension 473 7 46287-020-04 CaroSpir 118 mL in 1 BOTTLE Suspension 118 7 46287-020-50 CaroSpir 10 in 1 CARTON Suspension 10 7 46287-020-50 CaroSpir 5 mL in 1 CUP, UNIT-DOSE Suspension 5 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 46287-020 CAROSPIR SUSPENSION [CMP PHARMA, INC.] 6 Current NDC, Legacy NDC, 4 package rows 20230910_c4f70a04-7d89-4b73-8b02-17d43471bf08.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 46287-020-01 46287002001 473 mL in 1 BOTTLE (46287-020-01) 473 ml 2017-08-04 0000-00-00 No No Current 46287-020-04 46287002004 118 mL in 1 BOTTLE (46287-020-04) 118 ml 2017-08-04 0000-00-00 No No Current 46287-020-50 46287002050 10 CUP, UNIT-DOSE in 1 CARTON (46287-020-50) / 5 mL in 1 CUP, UNIT-DOSE 2021-07-15 0000-00-00 No No Current